TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 1, 2012
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics March 26, 1999
TCL Archive DeVita Says Payline Compression Leading to More Decisions By Staff On Funding June 28, 1985
TCL Archive NCI funds four radiation oncology cancer disparities research partnerships. October 10, 2003
